Somatostatin Receptor Expression in the Thyroid Demonstrated with 111In-Octreotide Scintigraphy
| Autor: | J. Wendler, Wolfgang Becker, M. Buchfelder, M. Gramatzki, U. Schrell, J. Hensen, F. Wolf |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
endocrine system
Pathology medicine.medical_specialty Goiter endocrine system diseases medicine.diagnostic_test Somatostatin receptor business.industry Thyroid disease Thyroid General Medicine Neuroendocrine tumors medicine.disease Scintigraphy medicine.anatomical_structure medicine Radiology Nuclear Medicine and imaging Euthyroid business Endocrine gland |
| Zdroj: | Nuklearmedizin. 34:100-103 |
| ISSN: | 2567-6407 0029-5566 |
| DOI: | 10.1055/s-0038-1629763 |
| Popis: | SummaryNeuroendocrine tumors with somatostatin receptor expression may be localized by 111ln-octreotide scintigraphy. This study examines those thyroid conditions where 111 ln-octreotide uptake could be observed also in the thyroid gland. 26 consecutive patients who underwent 111 ln-octreotide scintigraphy for tumor localization were additionally examined for thyroid disease by sonography and 99mTc-pertechnetate scintigraphy. 12 of these patients had no significant thyroid uptake and had an euthyroid normal-sized thyroid gland. 14 patiens with 111ln thyroid uptakes had endemic goiters, two of them with thyroid autonomy and one with Graves’ disease. Thus, 111 ln-octreotide thyroid uptake was predominantly seen in patients with endemic goiter with or without thyroid autonomy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|